Advanced Polycythemia
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies (NCT00807677) | Millennium Pharmaceuticals, Inc. | 2009-03-01 |
Track Advanced Polycythemia automatically
Every clearance here is in the API, with alerts when new ones post.